Jasper Therapeutics Inc.-CW26JSPRWPreferred / convertible
13F holders, Q4 2025 (December 31)9holders +1
1new positions
1sold out
$0.25avg. 13F price*
At the end of Q4 2025, 9 institutions reported holding Jasper Therapeutics Inc.-CW26 (JSPRW) in their 13F filings, up 1 from Q3 2025. 1 opened new positions and 1 sold out. The largest holders were Boothbay Fund Management, LLC ($654K), Toronto Dominion Bank ($88K) and TENOR CAPITAL MANAGEMENT Co., L.P. ($10K).
- Company
- Jasper Therapeutics Inc.-CW26
- CUSIP
- 471871111
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 1 | $3K |
All 13F filers, Q3 2025 → Q4 2025: 48,955 shares bought and 394,224 shares sold, net −345,269 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 9 holders
| Boothbay Fund Management, LLC | — | No change | 357,447 | $654K |
| Toronto Dominion Bank | — | Add +1.8% | 2,206,610 | $88K |
| TENOR CAPITAL MANAGEMENT Co., L.P. | — | No change | 250,000 | $10K |
| Walleye Capital LLC | — | Reduce -64.3% | 200,000 | $8K |
| T3 Companies, LLC | — | — | 14,200 | $569 |
| Bank of America Corp. | — | Reduce -1.0% | 100 | $4 |
| Clear Street Group Inc. | — | Reduce -16.7% | 100 | $4 |
| IFP Advisors, Inc | — | No change | 50 | $2 |
| Virtu Financial LLC | — | New | 10,114 | $0 |
"% of holder's portfolio" is JSPRW's weight in each manager's 13F, not the share of Jasper Therapeutics Inc.-CW26 the manager owns.